A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma

PURPOSE: The aim of our study was to propose a strategy based on indocyanine green (ICG) (SBI) to provide better clinical guidelines for transarterial chemoembolization (TACE) treatments for Barcelona clinic liver cancer (BCLC) stage C hepatocellular carcinoma (HCC) patients. MATERIALS AND METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Jie, Li, Shao‐Hua, Wang, Qiao‐Xuan, Zhong, Xiao‐Ping, Lu, Liang‐He, Kan, Anna, Wei, Wei, Guo, Rong‐Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943082/
https://www.ncbi.nlm.nih.gov/pubmed/31701652
http://dx.doi.org/10.1002/cam4.2671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943082/
https://www.ncbi.nlm.nih.gov/pubmed/31701652
http://dx.doi.org/10.1002/cam4.2671

Ejemplares similares